Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Yahoo FinanceMay 4 09:02 ET
Genomics Firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says
Thursday, Twist Bioscience Corporation (NASDAQ:TWST) reported a second-quarter EPS loss of $(0.79), better than a loss of $(1.04) a year ago and the consensus of $(0.81).The synthetic biology and geno
BenzingaMay 3 14:45 ET
Earnings Call Summary | Twist Bioscience(TWST.US) Q2 2024 Earnings Conference
The following is a summary of the Twist Bioscience Corporation (TWST) Q2 2024 Earnings Call Transcript:Financial Performance:Twist Bioscience Corporation reported Q2 2024 revenues of $75.3 million, a
moomoo AIMay 3 14:19 ET · Conference Call
Twist Bioscience Up Nearly 28%, on Pace for Largest Percent Increase Since November 2018 -- Data Talk
Twist Bioscience Corp. (TWST) is currently at $40.87, up $8.86 or 27.68% --Would be highest close since Feb. 27, 2024, when it closed at $40.99 --On pace for largest percent increase since Nov. 9, 2
Dow JonesMay 3 14:04 ET
Twist Biosciences Shares Rise 25% on Narrower-Than-Expected 2Q Loss
By Chris Wack Twist Biosciences shares were up 25% to $40.30 after the company reported narrower-than-expected second-quarter losses. The biotechnology company said it had a quarterly loss of $45.5
WSJMay 3 12:56 ET
RCAT, SMFL and NUVO Among Mid-day Movers
Seeking AlphaMay 3 12:51 ET
Twist Bioscience Price Target Raised to $50.00/Share From $46.00 by Evercore ISI Group
Twist Bioscience Price Target Raised to $50.00/Share From $46.00 by Evercore ISI Group
Dow JonesMay 3 12:32 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersEliem Therapeutics (NASDAQ:ELYM) shares moved upwards by 32.8% to $11.14 during Friday's regular session. The market value of their outstanding shares is at $308.8 million. Ardelyx (NASDAQ:ARDX
BenzingaMay 3 12:31 ET
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining over 400 points on Friday.Shares of Amgen Inc. (NASDAQ:AMGN) rose sharply during Friday's session after the company reported better-than-expec
BenzingaMay 3 10:15 ET
AEON Biopharma, Allarity Therapeutics, ModivCare Among Healthcare Movers
Seeking AlphaMay 3 10:00 ET
Twist Bioscience Is Maintained at Outperform by Baird
Twist Bioscience Is Maintained at Outperform by Baird
Dow JonesMay 3 07:13 ET
Express News | Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $40
BenzingaMay 3 07:02 ET
Twist Bioscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 15.94% Baird $39 → $40 Maintains Outperform 04/10/2024 15.94% Barclays $45 → $40 Maintains Over
BenzingaMay 3 07:01 ET
Express News | Twist Bioscience : Barclays Raises Target Price to $45 From $40
ReutersMay 3 06:27 ET
Express News | Twist Bioscience Corp : Evercore ISI Raises Target Price to $50.00 From $46.00
ReutersMay 3 04:39 ET
Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ...
Yahoo FinanceMay 3 04:05 ET
Express News | Twist Bioscience Corp : TD Cowen Raises Target Price to $55 From $48
ReutersMay 3 02:12 ET
Express News | Twist Bioscience Expects Total Revenue Of $77M For Q3 (Est $73.799M), $77M-$80M For Q4 (Est $77.172M)
BenzingaMay 2 17:17 ET
Express News | Twist Bioscience Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
BenzingaMay 2 17:14 ET
Express News | Twist Bioscience Corp Sees Q4 Total Revenue in Range of $77 Mln to $80 Mln
ReutersMay 2 16:33 ET
No Data
No Data